Pages in this set

Page 1

Preview of page 1
Issue date: November 2006 NHS
(amended September 2007)
Review date: September 2009
National Institute for
Health and Clinical Excellence
Quick reference guide

Donepezil, galantamine, rivastigmine (review)
and memantine for the treatment of
Alzheimer's disease (amended)
Following the outcome of a judicial review in August 2007, NICE has amended and reissued…

Page 2

Preview of page 2
1.2 In determining whether a patient has Alzheimer's 1.3 When the decision has been made to prescribe an
disease of moderate severity for the purposes of acetylcholinesterase inhibitor, it is recommended
section 1.1 above, healthcare professionals should that therapy should be initiated with a drug with
not rely, or rely…

Page 3

Preview of page 3
Further information `Understanding NICE guidance'
Quick reference guide Information for patients and their carers is available from
www.nice.org.uk/TA111publicinfo
This has been distributed to healthcare professionals
working in the NHS in England and Wales (see For printed copies, phone the NHS Response Line on
www.nice.org.uk/TA111distributionlist). It is available 0870 1555 455…

Page 4

Preview of page 4
Published by the National Institute for Health and Clinical Excellence, September 2007; ISBN 1-84629-473-8
© National Institute for Health and Clinical Excellence, September 2007. All rights reserved. This material may be freely
reproduced for educational and not-for-profit purposes. No reproduction by or for commercial organisations, or for
commercial purposes, is…

Comments

No comments have yet been made

Similar Psychology resources:

See all Psychology resources »See all resources »